BMC Pharmacology and Toxicology

NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-ß neuropathology in transgenic models of Alzheimer’s disease.

BMC Pharmacology and Toxicology

Gregory RJ Thatcher, Jia Luo, Lawren VandeVrede, Zhihui Qin, Sue Lee, Ramy Abdelhamid, Brian M Bennett, Mary Jo LaDu, Leon Tai, John Larson

Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway.

BMC Pharmacology and Toxicology

Marton I Siklos, Ronak P Gandhi, Rui Xiong, Isaac T Schiefer, Vladislav Litosh, Lawren VandeVrede, Gregory RJ Thatcher

NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-ß neuropathology in transgenic models of Alzheimer’s disease.

BMC Pharmacology and Toxicology

Gregory RJ Thatcher,Jia Luo,Lawren VandeVrede,Zhihui Qin,Sue Lee,Ramy Abdelhamid,Brian M Bennett,Mary Jo LaDu,Leon Tai,John Larson

Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway.

BMC Pharmacology and Toxicology

Marton I Siklos,Ronak P Gandhi,Rui Xiong,Isaac T Schiefer,Vladislav Litosh,Lawren VandeVrede,Gregory RJ Thatcher